Aspire Biopharma Holdings (ASBP) Other Working Capital Changes (2025 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly Other Working Capital Changes came in at $835047.0 in Q1 2026, up 114.33% year-on-year from $389615.0 in Q1 2025, and up 114.33% on a QoQ basis from $389615.0 in Q1 2025.
Aspire Biopharma Holdings (ASBP) Other Working Capital Changes (2025 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 2 years of Other Working Capital Changes data on file, last reported at $835047.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Aspire Biopharma Holdings | 1.07 Mn | -758,151.27 | 5,750.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 835,047.00 |
| Mar 31, 2026 | 835,047.00 |
| Mar 31, 2026 | 835,047.00 |
| Mar 31, 2025 | 389,615.00 |
| Mar 31, 2025 | 389,615.00 |
| Mar 31, 2025 | 389,615.00 |